Search Results 501-510 of 14847 for anti-TNF drugs

1. Pentostatin (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Drospirenone And Estetrol (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Fam-Trastuzumab Deruxtecan-Nxki (Intravenous Route) Description and Brand Names - Mayo Clinic

   ... anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for ...

4. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-tumor necrosis factor (TNF)-α agents, integrin inhibitor. Exclusion ...

5. Fosinopril And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Sulfasalazine (Oral Route) Before Using - Mayo Clinic

   ... drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the ...

7. Tobramycin (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Ophthalmic tobramycin may be used alone or with other medicines for eye infections. Either the drops or the ointment form of this medicine may be used alone ...

8. Androgen (Oral Route, Parenteral Route, Subcutaneous Route, Topical Application Route, Transdermal Route) Proper Use - Mayo Clinic

   For oral dosage form (tablets):. For androgen hormone replacement in men: Adults—5 milligrams (mg) one to four times a day. For treatment of ...

9. A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) - Mayo Clinic

   A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin ...

10. Decongestant And Analgesic Combinations (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...